Privacy PolicyTerms of Service
OslerMarket
K
Ask OslerLibraryLearn
OslerMarket

Filtered resources

Clinical library

444 resources

Explore a topic. Choose a collection. Find your next resource.

444 resources
Clear filters

Collections 3

Cardiology: ACS & Heart Failure16 resourcesHypertension9 resourcesECG & More17 resources

Collections

3 of 45
  • Cardiology: ACS & Heart Failure16 resourcesACS by Labu Albert · MANAGEMENT OF ACUTE CORONARY SYNDROME …
  • Hypertension9 resources2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults · ESC 2024 Hypertension Guidelines …
  • ECG & More17 resourcesAN INTRODUCTION TO THE ECG and arrythmias revision ECG Oct 2025 (2) · LITTLE BLACK BOOK OF ECG SECRETS …

Resources

24 shown
ADVANCES IN CONGESTION ASSESSMENT IN DECOMPENSATED HEART FAILURE coverClinical reviewsADVANCES IN CONGESTION ASSESSMENT IN DECOMPENSATED HEART FAILUREEssex Cardiothoracic Centre, Mid and South Essex NHS Foundation Trust; Anglia Ruskin University School of Medicine and Medical Technical Research Centre·Cardiology· 2026· 10 pagesThis review explores traditional and emerging methods for evaluating congestion in acute decompensated heart failure (ADHF) and assesses their role in enhancing clinical management. Accurate assessment of congestion is crucial for guiding diuretic treatment and preventing rehospitalisation.
ASSESSING CONGESTION IN HEART FAILURE: TOOLS ARE ALREADY AVAILABLE, BUT INTEGRATION IS KEY coverClinical reviewsASSESSING CONGESTION IN HEART FAILURE: TOOLS ARE ALREADY AVAILABLE, BUT INTEGRATION IS KEYINSERM UMR-S 942, Université de Paris Cité, Paris, France·Cardiology· 2026· 14 pagesThis review summarizes current and emerging approaches for evaluating congestion in heart failure, emphasizing the need for integration of clinical, imaging, hemodynamic, and patient-centered strategies for optimal management.
PHARMACOTHERAPY OF HEART FAILURE A.D. 2023 coverClinical reviewsPHARMACOTHERAPY OF HEART FAILURE A.D. 2023Medical University of Lodz, Collegium Medicum Jan Kochanowski University, Maria Skłodowska-Curie Medical Academy, Medical University of Warsaw, Świętokrzyskie Cardiology Center·Cardiology· 2023· 20 pagesThis document provides expert opinions on the pharmacotherapy of heart failure, focusing on recent advancements and recommendations in treatment strategies.
ASPIRIN WITH OR WITHOUT STATIN IN INDIVIDUALS WITHOUT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE ACROSS RISK CATEGORIES coverClinical reviewsASPIRIN WITH OR WITHOUT STATIN IN INDIVIDUALS WITHOUT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE ACROSS RISK CATEGORIESAmerican College of Cardiology Foundation·Cardiology· 2023· 12 pagesThis study examines the effects of aspirin in adults without atherosclerotic cardiovascular disease, stratified by statin use across different ASCVD risks.
EASY-WPW: a novel ECG-algorithm for easy and reliable localization of manifest accessory pathways in children and adults coverClinical reviewsEASY-WPW: a novel ECG-algorithm for easy and reliable localization of manifest accessory pathways in children and adultsHerz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Georgstr. 11, 32545 Bad Oeynhausen, Germany·Cardiology· 2022· 10 pagesThis clinical research paper introduces the EASY-WPW algorithm, a new electrocardiogram (ECG) based method designed for the accurate and straightforward localization of accessory pathways in both pediatric and adult patients. The study evaluates its performance against existing algorithms.
ACUTE CORONARY SYNDROMES coverClinical notesACUTE CORONARY SYNDROMESDr. Daniel Iraguha·Cardiology· 42 pagesThis document discusses acute coronary syndromes (ACS), including STEMI, NSTEMI, and unstable angina, highlighting their global impact, incidence, and management strategies.
ANTIARRHYTHMIC DRUG THERAPY FOR ACUTE MANAGEMENT OF ATRIAL FIBRILLATION AND ATRIAL FLUTTER coverClinical reviewsANTIARRHYTHMIC DRUG THERAPY FOR ACUTE MANAGEMENT OF ATRIAL FIBRILLATION AND ATRIAL FLUTTERMohammadali Habibi, MD; Muhammed Rahim, MD; Suneet Mittal, MD·Cardiology· 9 pagesThis document discusses the management of acute atrial fibrillation (AF) and atrial flutter (AFL) through antiarrhythmic drug therapy, emphasizing the importance of rate and rhythm control.
VALVULAR HEART FAILURE DUE TO TRICUSPID REGURGITATION SURGICAL AND TRANSCATHETER MANAGEMENT OPTIONS coverClinical reviewsVALVULAR HEART FAILURE DUE TO TRICUSPID REGURGITATION SURGICAL AND TRANSCATHETER MANAGEMENT OPTIONSColumbia University·Cardiology· 15 pagesThis document discusses the surgical and transcatheter management options for valvular heart failure due to tricuspid regurgitation, highlighting the importance of understanding the condition's etiology and treatment strategies.
WITHDRAWAL OF PHARMACOLOGICAL TREATMENT FOR HEART FAILURE IN PATIENTS WITH RECOVERED DILATED CARDIOMYOPATHY (TRED-HF): AN OPEN-LABEL, PILOT, RANDOMISED TRIAL coverClinical reviewsWITHDRAWAL OF PHARMACOLOGICAL TREATMENT FOR HEART FAILURE IN PATIENTS WITH RECOVERED DILATED CARDIOMYOPATHY (TRED-HF): AN OPEN-LABEL, PILOT, RANDOMISED TRIALRoyal Brompton and Harefield NHS Foundation Trust, London, UK·Cardiology· 13 pagesThis document presents a pilot randomized trial examining the safety and effects of withdrawing heart failure medications in patients with recovered dilated cardiomyopathy.
CARDIAC TUMORS: DIAGNOSIS, PROGNOSIS, AND TREATMENT coverClinical reviewsCARDIAC TUMORS: DIAGNOSIS, PROGNOSIS, AND TREATMENTRossana Bussani, Matteo Castrichini, Luca Restivo, Enrico Fabris, Aldostefano Porcari, Federico Ferro, Alberto Pivetta, Renata Korcova, Chiara Cappelletto, Paolo Manca, Vincenzo Nuzzi, Riccardo Bessi, Linda Pagura, Laura Massa, Gianfranco Sinagra·Cardiology· 2020· 13 pagesThis document provides an overview of cardiac tumors, discussing their epidemiology, imaging, histopathology, diagnostic workup, treatment, and prognoses. It highlights the challenges in diagnosing and managing these rare tumors.
WORSENING OF CHRONIC HEART FAILURE: DEFINITION, EPIDEMIOLOGY, MANAGEMENT AND PREVENTION. A CLINICAL CONSENSUS STATEMENT BY THE HEART FAILURE ASSOCIATION (HFA) OF THE ESC coverClinical reviewsWORSENING OF CHRONIC HEART FAILURE: DEFINITION, EPIDEMIOLOGY, MANAGEMENT AND PREVENTION. A CLINICAL CONSENSUS STATEMENT BY THE HEART FAILURE ASSOCIATION (HFA) OF THE ESCHeart Failure Association of the European Society of Cardiology·Cardiology· 2023· 39 pagesThis document provides a comprehensive consensus statement on the definition, epidemiology, management, and prevention of worsening chronic heart failure, developed by the Heart Failure Association of the European Society of Cardiology.
ACUTE MITRAL REGURGITATION coverClinical reviewsACUTE MITRAL REGURGITATIONMiyazaki Medical Association Hospital Cardiovascular Center·Cardiology· 2019· 7 pagesThis document discusses the diagnosis and management of acute mitral regurgitation (MR), highlighting the differences from chronic MR and the challenges in treatment based on various aetiologies.
THROMBOTIC AND BLEEDING COMPLICATIONS DURING ANTITHROMBOTIC TREATMENT: THE NEED FOR NEW THERAPEUTIC TARGETS coverClinical reviewsTHROMBOTIC AND BLEEDING COMPLICATIONS DURING ANTITHROMBOTIC TREATMENT: THE NEED FOR NEW THERAPEUTIC TARGETSDepartment of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy·Cardiology· 4 pagesThis document discusses the significant advancements in pharmacological management for cardiovascular disease patients using antithrombotic agents, while highlighting the persistent risks of bleeding complications.
HEART FAILURE WITH IMPROVED EJECTION FRACTION coverClinical reviewsHEART FAILURE WITH IMPROVED EJECTION FRACTIONAmerican College of Cardiology Foundation·Cardiology· 2025· 15 pagesThis document provides an in-depth evaluation of heart failure with improved ejection fraction (HFimpEF), including its epidemiology, pathophysiology, prognosis, and treatment strategies.
Management of Cardiogenic Shock in Patients with Acute Myocardial Infarction coverClinical reviewsManagement of Cardiogenic Shock in Patients with Acute Myocardial InfarctionKatherine J. Kunkel, MD, MSEd, Brittany Fuller, MD, Mir B. Basir, DO·Cardiology· 13 pagesThis document discusses the management strategies for cardiogenic shock in patients experiencing acute myocardial infarction, emphasizing the importance of early identification and mechanical support.
SYSTEMATIC REVIEW AND META-ANALYSIS OF DIAGNOSTIC TEST ACCURACY OF ST-SEGMENT ELEVATION FOR ACUTE CORONARY OCCLUSION coverClinical reviewsSYSTEMATIC REVIEW AND META-ANALYSIS OF DIAGNOSTIC TEST ACCURACY OF ST-SEGMENT ELEVATION FOR ACUTE CORONARY OCCLUSIONInstituto Dante Pazzanese de Cardiologia, São Paulo, Brazil·Cardiology· 2021· 7 pagesThis systematic review evaluates the diagnostic sensitivity and specificity of ST-segment elevation on a 12-lead ECG in detecting acute coronary occlusion (ACO). It challenges the current STEMI-NSTEMI paradigm by analyzing data from multiple studies.
BEYOND THE 4 PILLARS coverClinical reviewsBEYOND THE 4 PILLARSCittà della Salute e della Scienza Hospital, Turin, Italy·Cardiology· 4 pagesThis editorial comment discusses the role of vericiguat in the management of heart failure with reduced ejection fraction (HFrEF), emphasizing its potential benefits and the challenges in treatment outcomes.
ALDOSTERONE SYNTHASE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE coverClinical reviewsALDOSTERONE SYNTHASE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASEGian Paolo Rossi, Federico Bernardo Rossi, Andrea Cignarella, Teresa Maria Seccia·Cardiology· 2026· 11 pagesThis review discusses the role of aldosterone synthase inhibitors (ASIs) in managing cardiovascular diseases, particularly focusing on their efficacy in lowering aldosterone levels and blood pressure in patients with resistant hypertension.
TIME TO MOVE BEYOND THE STATIN NOCEBO EFFECT coverClinical reviewsTIME TO MOVE BEYOND THE STATIN NOCEBO EFFECTYale School of Medicine·Cardiology· 3 pagesThis editorial discusses the challenges associated with statin therapy, particularly the nocebo effect that leads many patients to discontinue their medication despite its proven benefits in cardiovascular prevention.
FEMORAL VEIN PULSATILITY: A SIMPLE TOOL FOR VENOUS CONGESTION ASSESSMENT coverClinical reviewsFEMORAL VEIN PULSATILITY: A SIMPLE TOOL FOR VENOUS CONGESTION ASSESSMENTV. Bhardwaj, P. Rola, A. Denault, G. Vikneswaran, R. Spiegel·Cardiology· 10 pagesThis article discusses the use of femoral vein Doppler (FVD) as a simpler alternative to the VExUS score for assessing venous congestion in adult post-cardiac surgery patients.
SAFETY, TOLERABILITY, AND EFFICACY OF UP-TITRATION OF GUIDELINE-DIRECTED MEDICAL THERAPIES FOR ACUTE HEART FAILURE (STRONG-HF): A MULTINATIONAL, OPEN-LABEL, RANDOMISED, TRIAL coverClinical reviewsSAFETY, TOLERABILITY, AND EFFICACY OF UP-TITRATION OF GUIDELINE-DIRECTED MEDICAL THERAPIES FOR ACUTE HEART FAILURE (STRONG-HF): A MULTINATIONAL, OPEN-LABEL, RANDOMISED, TRIALUniversité Paris Cité, INSERM UMR-S 942 (MASCOT), Paris, France·Cardiology· 2022· 15 pagesThis document presents the findings of a multinational trial assessing the safety, tolerability, and efficacy of up-titration of guideline-directed medical therapies in patients with acute heart failure.
CURRENT CONCEPTS IN CORONARY ARTERY REVASCULARISATION coverClinical reviewsCURRENT CONCEPTS IN CORONARY ARTERY REVASCULARISATIONDepartment of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA; Department of Cardiovascular, Policlinico Universitario Gemelli IRCCS, Rome, Italy; Osaka Hospital, Osaka, Japan·Cardiology· 2023· 18 pagesThis document discusses the methods of coronary artery revascularisation, including surgical and percutaneous approaches, highlighting their respective risks and benefits. It emphasizes the importance of medical therapy in conjunction with revascularisation.
THE ROLE OF β-BLOCKERS IN THE EVOLVING TREATMENT LANDSCAPE OF RESISTANT HYPERTENSION coverClinical reviewsTHE ROLE OF β-BLOCKERS IN THE EVOLVING TREATMENT LANDSCAPE OF RESISTANT HYPERTENSIONStefano Masi, Atul Pathak, Rosa Maria Bruno, Sofie Brouwers, Krzysztof Narkiewicz, Stefano Taddei, Konstantinos Tsioufis, Reinhold Kreutz·Cardiology· 2026· 21 pagesThis narrative review summarizes mechanistic insights and evidence from clinical trials and real-world studies regarding the management of resistant hypertension (RHTN), focusing on the role of β-blockers.
EXPERTS' RECOMMENDATIONS FOR THE MANAGEMENT OF ADULT PATIENTS WITH CARDIOGENIC SHOCK coverGuidelines & protocolsEXPERTS' RECOMMENDATIONS FOR THE MANAGEMENT OF ADULT PATIENTS WITH CARDIOGENIC SHOCKHôpital Européen Georges Pompidou, Toulouse University Hospital, University Hospital of Strasbourg, and others·Cardiology· 19 pagesThis document provides expert recommendations for the management of adult patients experiencing cardiogenic shock, focusing on various treatment modalities and their outcomes.
PreviousPage 8 of 19Next

© 2026 Osler Market

Library·Ask Osler·Learn·Terms·Privacy·Support·WhatsApp Channel

For learning purposes. Always consult clinical guidelines.

Ask OslerLibraryLearn
HomeAskLibraryLearnAccount